3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
60
Neoplasms
58
Lung Neoplasms
32
Prostatic Neoplasms
24
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
21
Neoplastic Cells, Circulating
20
Head and Neck Neoplasms
19
Pancreatic Neoplasms
17
Melanoma
14
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
12
Esophageal Neoplasms
10
Colonic Neoplasms
10
Uterine Cervical Neoplasms
9
Liver Neoplasms
9
Glioma
9
Squamous Cell Carcinoma of Head and Neck
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Neoplasm Metastasis
7
Endometrial Neoplasms
7
Stomach Neoplasms
6
Neoplasm, Residual
6
Myeloproliferative Disorders
6
Leukemia
6
Kidney Neoplasms
6
Gastrointestinal Neoplasms
6
Carcinoma, Renal Cell
6
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Vascular Stiffness
1
Ultrasonography
1
Topiramate
1
Tirzepatide
1
Testosterone
1
Qsymia
1
Pulse Wave Analysis
1
Pioglitazone
1
Phentermine
1
Observation
1
Naltrexone
1
Medical History Taking
1
Liraglutide
1
Human Growth Hormone
1
Hematologic Tests
1
Growth Hormone
1
Gonadotropin-Releasing Hormone
1
Glucagon-Like Peptide-1 Receptor
1
Gastric Bypass
1
Electrocardiography
1
Echocardiography
1
Diethylpropion
1
Dietary Approaches To Stop Hypertension
1
DNA
1
Colonoscopy
1
Bupropion
1
Blood Specimen Collection
1
Blood Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Metabolic Syndrome
×
Blood Specimen Collection
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled